Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

White Paper AGA: Functional Dyspepsia.

Vakil NB, Howden CW, Moayyedi P, Tack J.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1191-1194. doi: 10.1016/j.cgh.2017.05.013. Epub 2017 May 18.

PMID:
28529164
2.

American Gastroenterological Association Drug Development Conferences: A Model for Future Collaborations.

Howden CW, Vakil NB.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1195-1196. doi: 10.1016/j.cgh.2017.02.035. Epub 2017 Mar 12. No abstract available.

PMID:
28300692
3.

Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference.

Howden CW, Vakil NB.

Gastroenterology. 2017 Mar;152(4):e1-e4. doi: 10.1053/j.gastro.2017.01.034. Epub 2017 Jan 29. No abstract available.

PMID:
28147223
4.
5.

Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease--insights into study design for transient lower sphincter relaxation inhibitors.

Vakil NB, Huff FJ, Cundy KC.

Aliment Pharmacol Ther. 2013 Jul;38(2):107-17. doi: 10.1111/apt.12363. Epub 2013 May 30.

6.

Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms.

Vakil NB, Halling K, Becher A, Rydén A.

Eur J Gastroenterol Hepatol. 2013 Jan;25(1):2-14. doi: 10.1097/MEG.0b013e328358bf74. Review.

PMID:
23202695
7.

Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study.

Vakil NB, Huff FJ, Bian A, Jones DS, Stamler D.

Am J Gastroenterol. 2011 Aug;106(8):1427-38. doi: 10.1038/ajg.2011.121. Epub 2011 Apr 26.

PMID:
21519360
8.

Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?

Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, Vakil NB, Simel DL, Moayyedi P.

JAMA. 2008 Oct 15;300(15):1793-805. doi: 10.1001/jama.300.15.1793. Review. Erratum in: JAMA. 2009 Apr 15;301(15):1544.

PMID:
18854541
9.

Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis.

Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P.

Gut. 2008 Nov;57(11):1545-53. doi: 10.1136/gut.2008.159723. Epub 2008 Aug 1. Review.

PMID:
18676420
10.

A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States.

Barton PM, Moayyedi P, Talley NJ, Vakil NB, Delaney BC.

Med Decis Making. 2008 Jan-Feb;28(1):44-55. Epub 2007 Dec 5.

PMID:
18057189
11.

American gastroenterological association technical review on the evaluation of dyspepsia.

Talley NJ, Vakil NB, Moayyedi P.

Gastroenterology. 2005 Nov;129(5):1756-80. Review. No abstract available.

PMID:
16285971
12.
13.

Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment.

Vakil NB, Traxler B, Levine D.

Clin Gastroenterol Hepatol. 2004 Aug;2(8):665-8.

PMID:
15290658
14.

Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies.

Spiegel BM, Ofman JJ, Woods K, Vakil NB.

Am J Gastroenterol. 2003 Jan;98(1):86-97.

PMID:
12526942
15.

Comparison of inter- and intraobserver consistency for grading of esophagitis by expert and trainee endoscopists.

Pandolfino JE, Vakil NB, Kahrilas PJ.

Gastrointest Endosc. 2002 Nov;56(5):639-43.

PMID:
12397269
16.

Dyspepsia management in primary care: a decision analysis of competing strategies.

Spiegel BM, Vakil NB, Ofman JJ.

Gastroenterology. 2002 May;122(5):1270-85. No abstract available.

PMID:
11984514
17.

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG.

Am J Gastroenterol. 2002 Mar;97(3):575-83.

PMID:
11922549
18.

Review article: gastro-oesophageal reflux disease and Helicobacter pylori infection.

Vakil NB.

Aliment Pharmacol Ther. 2002 Mar;16 Suppl 1:47-51. Review.

19.
20.

Endoscopy for acute nonvariceal upper gastrointestinal tract hemorrhage: is sooner better? A systematic review.

Spiegel BM, Vakil NB, Ofman JJ.

Arch Intern Med. 2001 Jun 11;161(11):1393-404. Review.

PMID:
11386888
21.

Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis.

Maton PN, Vakil NB, Levine JG, Hwang C, Skammer W, Lundborg P; Esomeprazole Study Investigators.

Drug Saf. 2001;24(8):625-35.

PMID:
11480494
22.
23.

Debating the role of Helicobacter pylori infection.

Vakil NB, Go MF.

Am J Manag Care. 2001 Feb;7(1 Suppl):S27-32. Review.

24.

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.

Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, Damico D, Hamelin B.

Am J Gastroenterol. 2001 Jan;96(1):27-34. Erratum in: Am J Gastroenterol 2001 Mar;96(3):942.

PMID:
11197282
25.

A surgical nirvana for GERD sufferers?

Vakil NB, Hernandez LV.

Am J Gastroenterol. 2000 Jun;95(6):1586. No abstract available.

PMID:
10894604
26.

Identification of a novel penicillin-binding protein from Helicobacter pylori.

Krishnamurthy P, Parlow MH, Schneider J, Burroughs S, Wickland C, Vakil NB, Dunn BE, Phadnis SH.

J Bacteriol. 1999 Aug;181(16):5107-10.

27.

Helicobacter pylori containing only cytoplasmic urease is susceptible to acid.

Krishnamurthy P, Parlow M, Zitzer JB, Vakil NB, Mobley HL, Levy M, Phadnis SH, Dunn BE.

Infect Immun. 1998 Nov;66(11):5060-6.

28.

Antibiotic-induced iatrogenic hemobilia.

Huilgol VR, Markus SL, Vakil NB.

Am J Gastroenterol. 1997 Apr;92(4):706-7. Review.

PMID:
9128332
29.

Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies.

Dunn BE, Vakil NB, Schneider BG, Miller MM, Zitzer JB, Peutz T, Phadnis SH.

Infect Immun. 1997 Apr;65(4):1181-8.

30.

Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee.

Vakil NB, Schwartz SM, Buggy BP, Brummitt CF, Kherellah M, Letzer DM, Gilson IH, Jones PG.

N Engl J Med. 1996 Jan 4;334(1):19-23.

31.

The benefit of head rotation on pharyngoesophageal dysphagia.

Logemann JA, Kahrilas PJ, Kobara M, Vakil NB.

Arch Phys Med Rehabil. 1989 Oct;70(10):767-71.

PMID:
2802957
32.

Absence of an upper esophageal sphincter response to acid reflux.

Vakil NB, Kahrilas PJ, Dodds WJ, Vanagunas A.

Am J Gastroenterol. 1989 Jun;84(6):606-10.

PMID:
2729231
33.

Emergencies of the biliary tract.

Sievert W, Vakil NB.

Gastroenterol Clin North Am. 1988 Jun;17(2):245-64. Review.

PMID:
3049344
34.

Splenic and orbital hydatid cysts and treatment with mebendazole (a case report).

Agarwal MB, Kamdar MS, Tilve GH, Bapat RD, Vakil NB, Desai MB.

J Postgrad Med. 1982 Apr;28(2):115-7. No abstract available.

35.

Waldenström's macroglobulinemia. (A case report).

Vakil NB, Agarwal MB, Tilve GH.

J Postgrad Med. 1982;28(4):238-40. No abstract available.

36.

Neurosyphilis-an unusual presentation: (a case report).

Medhekar TP, Vakil NB, Dalvi SG.

J Postgrad Med. 1981 Oct;27(4):245-7. No abstract available.

PMID:
7338831

Supplemental Content

Loading ...
Support Center